Conference call regarding Elekta’s Interim Report for May-July 2014/15
· The report will be published at 13:00 CET.
· Elekta will host a telephone conference at 13:45-14:30 CET with Niklas Savander, President and CEO and Håkan Bergström, CFO.
To take part in the conference call, please dial in about five minutes in advance, use the telephone numbers below.
- UK dial-in number: +44 20 319 405 47
- US dial-in number: +1 877 788 90 23
- Swedish dial-in number: +46 8 519 993 50
The telephone conference will be broadcasted live online (for the possibility to ask questions, please also dial in). Please use the link: http://event.onlineseminarsolutions.com/r.htm?e=835942&s=1&k=EAA8B50F1C78794463BD4A565734355A
# # #
For further information, please contact:
Johan Andersson, Director Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: email@example.com
Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: firstname.lastname@example.org
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.